Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
University College London Hospitals NHS Foundation Trust (UCLH) is a leading healthcare provider and research institution based in London, United Kingdom. As a major member of the National Health Service (NHS), it operates several world-renowned specialist hospitals, including the National Hospital for Neurology and Neurosurgery and the University College Hospital Elizabeth Garrett Anderson Wing. UCLH is a global leader in translational research, working in close partnership with University College London (UCL) to bridge the gap between laboratory discoveries and patient care. The trust hosts the NIHR UCLH Biomedical Research Centre, which supports a vast portfolio of clinical trials across therapeutic areas such as oncology, neurology, and hematology. UCLH is particularly recognized for its pioneering work in advanced therapeutics, including CAR-T cell therapies and experimental treatments for neurodegenerative diseases. It also houses one of the UK's two high-energy proton beam therapy centers, providing advanced cancer treatment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UCLH.